Caltech scientists have already engineered stem cells into B cells that produce HIV-fighting antibodies – and an NIH researcher engineered T cells that recognize tumors which has already had promising clinical trials again skin cancer. Now a microbiology professor now asks: could we just genetically engineer all the antibodies we need?
Describing “Immunity on demand, he writes “…there’s a good chance this system, or something like it, will actually be in place within decades!”
“Our best hope may be to cut out the middleman. Rather than merely hoping that the vaccine will indirectly lead to the antibody an individual needs, imagine if we could genetically engineer these antibodies and make them available as needed?”